S&P 500 Consumer Staples Sector SEC Filings — May 19, 2026

19-05-2026

Stellar Bancorp, Inc. is urging shareholders to take immediate action regarding their investment(s) ahead of a May 26, 2026 deadline, in connection with the proposed acquisition by Prosperity Bancshares, Inc. The transaction, which involves the issuance of Prosperity common stock to Stellar shareholders, is subject to shareholder approval and other closing conditions. While the filing highlights the need for shareholder participation, it also outlines significant risks, including potential failure to obtain shareholder approval, integration challenges, and dilution from the issuance of additional shares.

• · The definitive proxy statement/prospectus was mailed to Stellar shareholders on April 23, 2026.
• · The Registration Statement on Form S-4 (File No. 333-294882) was declared effective on April 21, 2026.
• · Shareholders are asked to contact Georgeson LLC toll-free at (888) 463-8808 before May 26, 2026.
• · Risks include failure to obtain necessary shareholder approval, integration difficulties, and dilution from the issuance of additional Prosperity common stock.
• · The filing does not provide any financial figures or performance metrics for Stellar Bancorp.

19-05-2026

Blackstone Mortgage Trust, Inc. (BXMT) completed a $450M offering of 6.250% Senior Secured Notes due 2031 on May 19, 2026. The notes are secured on a first-priority basis by substantially all assets of the company and its guarantors, and proceeds will be used for general corporate purposes including paying down existing secured debt. The issuance increases the company's leverage and interest expense, but provides liquidity for refinancing.

• · The notes were issued in a private offering under Rule 144A and Regulation S.
• · Interest is payable semi-annually on June 1 and December 1, commencing December 1, 2026.
• · The notes mature on June 1, 2031.
• · Optional redemption before March 1, 2031 requires a make-whole premium; on or after that date, redemption is at par plus accrued interest.
• · Up to 40% of the notes can be redeemed before December 1, 2027 using proceeds from certain equity offerings at a price of 106.250%.
• · A change of control triggering event requires the company to offer to repurchase notes at 101% of principal plus accrued interest.
• · The notes are senior secured obligations ranking pari passu with existing First Lien Obligations, including the Term Loan Credit Agreement and the 3.750% and 7.750% Senior Secured Notes.
• · The notes are secured by substantially all assets of the company and guarantors on a first-priority basis, subject to a first lien intercreditor agreement dated October 5, 2021.
• · Upon a Collateral Fall-Away Event, the notes become unsecured.
• · Covenants include a maximum Total Debt to Total Assets Ratio of 83.333% before a Collateral Fall-Away Event and a minimum Total Unencumbered Assets to Total Unsecured Indebtedness Ratio of 1.20 to 1.00 after.
• · The indenture includes events of default that could accelerate repayment of all outstanding notes.

19-05-2026

Primo Brands Corp (PRMB) appointed Andrea Brimmer as a new independent director on May 15, 2026, increasing the Board size from 10 to 11 members. Ms. Brimmer, 60, is Chief Marketing and Public Relations Officer at Ally Financial Inc. and also serves on the board of eHealth, Inc. She will also join the Board's Sustainability Committee. The filing does not include any financial results or period-over-period comparisons.

• · Ms. Brimmer has served as Chief Marketing and Public Relations Officer of Ally Financial Inc. since 2015.
• · She has served as a director of eHealth, Inc. since December 2018.
• · She also serves on the boards of the Women’s Sports Foundation, the Ad Council and the Detroit Sports Commission.
• · Ms. Brimmer holds a Bachelor of Science degree in advertising from Michigan State University.
• · No transactions requiring Item 404(a) disclosure exist involving Ms. Brimmer.
• · She will receive compensation under the standard Non-Employee Director Compensation Program as disclosed in the proxy statement filed March 18, 2026.
• · The Company will enter into its standard form of indemnification agreement with Ms. Brimmer.

19-05-2026

Novelis Inc. reported Q4 FY2026 net loss of $84M vs net income of $294M in the prior year, severely impacted by two fires at its Oswego plant. Full-year net income plunged 98% to $15M. Adjusted EBITDA fell 3% YoY in Q4 to $459M and 9% for the full year to $1.6B, with Oswego fires causing an estimated $104M EBITDA hit and tariffs adding $143M in costs. However, Q4 adjusted EBITDA per tonne rose 10% increased 10% YoY to $544, and the Oswego hot mill is expected to restart ahead of schedule, providing a path to recovery.

19-05-2026

Kensington Investment Counsel, LLC filed its 13F-HR for the quarter ended March 31, 2026, reporting a portfolio value of approximately $207.7 million across 83 holdings. The largest positions include Apple Inc. ($15.6M), Microsoft Corp. ($11.2M), and Johnson & Johnson ($6.7M). The filing reflects the firm's equity holdings as of the reporting date.

• · The portfolio consists of 83 holdings with a total value of $207,728,431.
• · Top holdings by value: Apple Inc. ($15,557,327), Microsoft Corp. ($11,195,051), Johnson & Johnson ($6,699,856), AbbVie Inc. ($8,158,702), JPMorgan Chase & Co. ($8,116,757).
• · The filing includes common stocks, ETFs, ADRs, and REITs.
• · All holdings are listed with sole voting and dispositive power.

19-05-2026

Pinnacle West Capital Corporation held its Annual Meeting on May 14, 2026, where shareholders elected ten directors, approved an advisory vote on executive compensation, and ratified Deloitte & Touche LLP as independent accountant for 2026. All proposals passed with strong support, though there were notable broker non-votes and some withhold votes.

• · Proposal 1: All ten director nominees received over 99.5 million votes for, with the lowest being Glynis A. Bryan at 95,980,735 for and 5,797,567 withheld.
• · Proposal 2: Advisory vote on executive compensation passed with 98,755,016 for, 2,750,428 against, and 272,858 abstentions.
• · Proposal 3: Ratification of Deloitte & Touche LLP received 107,509,825 for, 2,819,186 against, and 165,273 abstentions.
• · Broker non-votes were 8,715,982 for each director election and for Proposal 2, but none for Proposal 3.

19-05-2026

Bridgeline Digital reported Q2 FY2026 revenue of $3.9M, flat YoY, and subscription revenue of $3.1M, also flat YoY. However, the company achieved record new customer wins with 19 new subscription contracts totaling $2.8M in total contract value and $875K in annual recurring revenue, while core subscription ARR per new customer doubled to $44,000 from $21,000. Net loss improved to $0.4M from $0.7M in the prior year period, but gross margin declined to 64% from 68%.

• · Core revenue grew to 61% of total revenue and 65% of subscription revenue, both increasing from prior quarter and prior year.
• · Subscription revenue as a percentage of total revenue improved to 80% from 79% YoY.
• · Services gross margin declined to 47% from 52% YoY.
• · Operating expenses decreased 11.8% YoY to $3.0M.
• · HawkSearch received multiple 2026 honors from Info-Tech Research Group including Leader in Enterprise Search.
• · A leading global gas provider selected HawkSearch for a technically complex multi-lingual, multi-site implementation.
• · A wholesale distributor selected HawkSearch across five sites on OroCommerce with potential expansion to eight sites.
• · A national industrial supplier selected HawkSearch for specification-driven catalog search.
• · An Australia-based global electrical wholesaler selected HawkSearch with expansion potential to a second website.
• · A leading home décor brand selected HawkSearch for four ecommerce sites, originated through a customer referral.
• · Barron Designs and AZ Faux, serving 270,000 monthly visitors, selected HawkSearch.
• · A leading industrial distributor, first Unilog customer using HawkSearch connector, selected after proof-of-concept.
• · Precision metalworking manufacturer with 80+ years heritage selected HawkSearch for WooCommerce platform.

19-05-2026

Wellgistics Health, Inc. (WGRX) filed an 8-K on May 19, 2026, announcing that it will report its first quarter 2026 financial results after market close on the same day. The press release was issued on May 15, 2026, and is furnished as Exhibit 99.1. No financial figures or performance comparisons are provided in this filing.

• · The press release was issued on May 15, 2026, and is furnished as Exhibit 99.1.
• · The filing is made under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits).
• · The company is an emerging growth company as defined under the Securities Act.
• · The report was signed on May 18, 2026, by CEO Prashant Patel.

19-05-2026

Thermon Group Holdings reported Q4 FY2026 revenue of $148.3M (+11% YoY) and full-year revenue of $536.3M (+8% YoY), with record Adjusted EBITDA of $119.6M (+9% YoY). However, GAAP net income declined sharply: Q4 net income fell 84% to $2.7M ($0.08 EPS) and full-year net income dropped 17% to $44.6M ($1.36 EPS), impacted by higher SG&A costs related to the pending CECO transaction and growth investments. The company's pending merger with CECO Environmental Corp. (valued at ~$2.2B) remains on track to close in June 2026, with stockholder votes scheduled for May 27, 2026.

• · Q4 FY2026 gross margin was 44.0%, down from 44.3% in Q4 FY2025 due to increased CAPEX activity and product mix.
• · Q4 FY2026 SG&A expenses rose to $52.3M from $32.8M in Q4 FY2025, driven by CECO transaction costs, growth investments, and higher performance-based compensation.
• · Adjusted EBITDA margin declined to 21.6% in Q4 FY2026 from 22.7% in Q4 FY2025 due to higher variable costs.
• · Full-year FY2026 Adjusted EBITDA margin improved to 22.3% from 21.9% in FY2025.
• · Book-to-bill ratio was 0.97x in Q4 FY2026 and 1.03x for full-year FY2026.
• · Working capital increased 21% YoY to $202.5M as of March 31, 2026.
• · Capital expenditures were $3.5M in Q4 FY2026, up 12.9% from $3.1M in Q4 FY2025.
• · The pending CECO merger is valued at approximately $2.2 billion, with CECO shareholders expected to own ~62.5% and Thermon shareholders ~37.5% of the combined company.
• · CECO reported strong Q1 2026 performance with revenue and adjusted EBITDA growth of 25% and 45%, respectively.
• · Thermon is not hosting a conference call and has withdrawn financial guidance due to the pending merger.

19-05-2026

Korro Bio, Inc. announced the addition of KRRO-111, a new therapeutic program targeting Alpha-1 Antitrypsin Deficiency (AATD), to its pipeline. The company also updated its corporate presentation for investor and analyst meetings. No financial results or performance metrics were disclosed in this filing.

• · The press release and updated corporate presentation were filed as Exhibits 99.1 and 99.2, respectively.
• · The filing date is May 19, 2026.
• · No financial statements or new financial data were included in this 8-K.

19-05-2026

36Kr Holdings Inc. disclosed in its 20-F/A filing that it was likely a passive foreign investment company (PFIC) for 2025, with significant risk of remaining a PFIC for 2026 and future taxable years due to current ADS trading prices. This PFIC status could lead to adverse U.S. federal income tax consequences for U.S. investors holding ADSs or Class A ordinary shares.

• · The PFIC determination is based on the company's asset composition and income for 2025.
• · U.S. investors may face higher tax rates and additional reporting requirements under PFIC rules.
• · The filing references page 42 of the annual report for further details on PFIC implications.

19-05-2026

BlueLinx Holdings Inc. held its 2026 Annual Meeting on May 14, 2026, where stockholders re-elected eight of nine director nominees, ratified Ernst & Young LLP as auditor, approved the advisory say-on-pay resolution, and approved an amendment to the 2021 Long-Term Incentive Plan to increase shares reserved for issuance. However, director Mitchell B. Lewis did not receive a majority of votes cast (2,604,527 for vs. 3,325,567 against) due to ISS and Glass Lewis 'against' recommendations over his Nominating Committee service, and he tendered his resignation, which the Board unanimously rejected, allowing him to remain as a director.

• · The 2021 Plan amendment to increase shares reserved for issuance was approved with 3,843,084 for, 2,090,468 against, and 1,599 abstain (plus 1,198,409 broker non-votes).
• · Ratification of Ernst & Young LLP passed overwhelmingly: 7,122,739 for, 10,258 against, 563 abstain.
• · Advisory say-on-pay resolution passed with 5,874,819 for, 55,435 against, 4,897 abstain (plus 1,198,409 broker non-votes).
• · Mr. Lewis resigned as Chairman and member of the Nominating Committee; Marietta Edmunds Zakas will replace him as Chairman.
• · The Board considered factors including Mr. Lewis's independence under NYSE standards (since December 2024) and his qualifications before rejecting his resignation.

19-05-2026

Educational Development Corporation reported fiscal 2026 net revenues of $22.9M, down 33% from $34.2M in the prior year, and a net loss of $3.1M in Q4 versus a $1.3M loss a year ago. The full-year net earnings of $2.3M were boosted by a $12.2M gain on the sale of the Hilti Complex, without which the company would have reported a pre-tax loss of $6.9M. While the company eliminated all bank debt and reduced inventory by $7.0M, its core PaperPie brand partner base shrank 53% to an average of 5,800, and Q4 revenues fell 37% year-over-year.

• · Loss before income taxes in Q4 FY2026 was $(2.1)M, a $0.6M decline from the prior year Q4 loss of $(1.5)M.
• · Income tax expense for FY2026 was $3.0M, including a one-time valuation allowance of $1.5M, resulting in an effective tax rate of 56.5%.
• · No dividends were paid in either fiscal 2026 or fiscal 2025.
• · The company executed a strategic restructuring at year-end, including executive pay reductions and a small reduction in force, expected to save over $1.2M in G&A expenses in fiscal 2027.
• · New titles began releasing in early fiscal 2027, with additional titles planned for summer and fall.
• · The company's weighted average diluted shares outstanding were 8,563,491 for FY2026 vs 8,348,971 for FY2025.

19-05-2026

Farmer Mac completed the issuance of 4,000,000 shares of 6.875% Non-Cumulative Preferred Stock, Series I, in an exempt public offering on May 19, 2026. The offering was made pursuant to an underwriting agreement dated May 12, 2026, with Morgan Stanley & Co. LLC as representative of the underwriters. No financial results or period-over-period comparisons are included in this filing.

• · The offering was exempt and made pursuant to an offering circular.
• · The underwriting agreement was dated May 12, 2026.
• · The filing does not include any financial statements or period-over-period comparisons.

19-05-2026

JBT Marel Corp held its Annual Meeting of Stockholders on May 14, 2026, with 46,668,495 shares represented (quorum). All ten director nominees were elected, the advisory vote on executive compensation passed with 92.6% support, and the ratification of PricewaterhouseCoopers as auditor for 2026 was overwhelmingly approved with 99.9% of votes cast. However, director Polly B. Kawalek received a notable 3.5% against vote (1,620,316 shares), the highest opposition among nominees, indicating some shareholder dissent.

• · Polly B. Kawalek received 1,620,316 votes AGAINST (3.5% of votes cast), the highest opposition among all director nominees.
• · All other director nominees received over 98% FOR votes, with Brian A. Deck and Ann E. Savage receiving the highest support (over 99.9% FOR).
• · The advisory vote on executive compensation had 3,116,022 votes AGAINST and 332,884 abstentions, representing about 7.4% opposition.
• · Ratification of PwC as auditor was nearly unanimous with only 25,979 votes AGAINST and 53,241 abstentions.
• · Broker non-votes totaled 1,140,646 shares across all proposals.

19-05-2026

Amkor Technology held its Annual Meeting of Stockholders on May 13, 2026, where all 11 director nominees were elected, the advisory vote on executive compensation passed, and the ratification of PricewaterhouseCoopers as independent auditor for 2026 was approved. All proposals received strong shareholder support, with the auditor ratification receiving the highest approval at approximately 98.9% of votes cast.

• · The highest vote 'for' among director nominees was Douglas A. Alexander with 214,938,039 votes; the lowest was Winston J. Churchill with 205,900,093 votes.
• · Advisory vote on executive compensation had 212,545,742 votes for, 4,838,618 against, and 107,629 abstentions.
• · Ratification of PricewaterhouseCoopers had 227,566,541 votes for, 2,589,888 against, and 69,218 abstentions, with no non-votes.
• · Total non-votes for director elections and the compensation vote were 12,733,658, reflecting shares not present or not voted on those items.

19-05-2026

Alamo Group Inc. announced the retirement of Richard H. Raborn, Executive Vice President of the Vegetation Management Division, effective May 29, 2026. Under a separation agreement, Mr. Raborn will receive severance equal to his current base salary of $536,000, payable over twelve months, subject to a release of claims. The separation is not related to any disagreement over the Company’s operations, financial reporting, or accounting practices.

• · Retirement effective date: May 29, 2026.
• · Severance payable over a twelve-month period following the last date of employment.
• · Filing made on May 19, 2026, with a report date of May 14, 2026.
• · Mr. Raborn's departure is not due to any disagreements regarding operations, financial reporting, or accounting practices.

19-05-2026

Ardelyx, Inc. filed a DEFA14A additional proxy soliciting material on May 19, 2026, referencing forward-looking statements originally filed with the SEC on April 30, 2026. The filing contains no new financial data or operational updates, only standard cautionary language regarding forward-looking statements and the company's disclaimers of any obligation to update them.

• · The filing is a DEFA14A (additional definitive proxy soliciting material) filed on May 19, 2026.
• · The content references forward-looking statements originally filed with the SEC on April 30, 2026.
• · The filing includes standard cautionary language that actual results could differ materially from forward-looking statements.
• · Ardelyx undertakes no obligation to update forward-looking statements except as required by law.

19-05-2026

At the 2026 Annual Meeting held on May 14, 2026, Kraft Heinz stockholders elected all 10 director nominees, approved executive compensation on an advisory basis, approved the amended 2020 Omnibus Incentive Plan, and ratified PricewaterhouseCoopers as independent auditors for 2026. While all proposals passed, director John T. Cahill and John C. Pope received notable opposition with 38.5 million and 26.9 million against votes respectively, and the advisory vote on executive compensation saw 51.1 million against votes, indicating some shareholder dissent.

• · Broker non-votes totaled 117,137,683 shares for all director elections and the advisory compensation vote, representing a significant portion of shares not voted on those items.
• · The ratification of PricewaterhouseCoopers as auditors received 955,089,151 for votes, the highest support among all proposals, with no broker non-votes.
• · Director John C. Pope received 26,922,158 against votes, the second-highest opposition among nominees after John T. Cahill.

19-05-2026

Celestica Inc. held its 2026 annual meeting on May 19, 2026, with approximately 66% of outstanding shares represented. All director nominees were elected, and shareholders approved the appointment of the auditor and the advisory vote on executive compensation. However, notable against votes were recorded for certain directors, with Laurette T. Koellner receiving the highest number of withheld votes at 5,326,212.

• · The record date for the meeting was March 27, 2026.
• · The definitive proxy statement was filed on April 9, 2026.
• · Broker non-votes for director elections totaled 3,943,843 shares for each nominee.
• · The advisory vote on executive compensation had 2,539,538 against and 919,400 abstentions.
• · The appointment of the auditor was approved with 70,403,709 for and 5,477,221 withheld.

19-05-2026

Pinnacle Financial Partners, Inc. completed a public offering of $750 million aggregate principal amount of 5.596% Fixed Rate / Floating Rate Senior Notes due 2032 on May 19, 2026. The notes bear a fixed rate of 5.596% for the first five years, then float at SOFR plus 1.70% for the final year. The offering was registered under the company's shelf registration statement and the notes were issued under a senior indenture with The Bank of New York Mellon Trust Company, N.A. as trustee.

• · The notes mature on May 19, 2032.
• · Interest is payable semi-annually during the fixed-rate period and quarterly during the floating-rate period.
• · The offering was made under shelf registration statement File No. 333-292560.
• · The base indenture was originally dated February 13, 2012, and was supplemented on January 1, 2026.
• · Legal opinions on the validity of the notes were provided by Wachtell, Lipton, Rosen & Katz and Allan E. Kamensky.

19-05-2026

Core Molding Technologies announced a CEO transition agreement with David L. Duvall, effective June 1, 2026, under which he will serve as a part-time advisor through December 31, 2027, receiving a monthly fee of $50,000. The agreement formalizes the previously disclosed planned retirement and advisory role. No financial results or period-over-period comparisons are included in this filing.

• · The Transition Agreement is effective June 1, 2026.
• · The Advisory Period runs from June 1, 2026 to December 31, 2027.
• · If terminated without Cause during the Advisory Period, Mr. Duvall is entitled to the remaining Monthly Fee for the Advisory Period.
• · The agreement was previously disclosed in an 8-K filed on August 5, 2025.

19-05-2026

Helen of Troy Limited approved an amended and restated Annual Incentive Plan on May 13, 2026, making administrative and technical updates including removal of references to Section 162(m), alignment with the 2025 Stock Incentive Plan, and clarification of delegation authority. The plan aims to provide bonus incentives tied to company performance.

• · The Plan removes references to Section 162(m) of the Internal Revenue Code due to changes in law.
• · The Plan aligns administrative provisions with the Company's 2025 Stock Incentive Plan, approved by stockholders at the 2025 Annual General Meeting.
• · The Plan clarifies that the Board or Compensation Committee may delegate authority to officers to set annual incentive opportunities for non-Named Executive Officers.

19-05-2026

Claros Mortgage Trust, Inc. filed a DEFA14A proxy statement for its 2026 Annual Meeting to be held virtually on June 3, 2026. The board recommends voting for the election of nine director nominees, ratification of PricewaterhouseCoopers as auditor, advisory approval of executive compensation, and approval of an amendment to the 2016 Incentive Award Plan. No financial results or performance metrics are included in this filing.

• · Annual Meeting date: June 3, 2026 at 1:00 p.m. Eastern Daylight Time
• · Virtual meeting link: www.virtualshareholdermeeting.com/CMTG2026
• · Voting deadline: June 2, 2026 at 11:59 PM ET
• · Proxy materials available at www.proxyvote.com
• · Paper/email copy request deadline: May 20, 2026

19-05-2026

HF Sinclair Corporation (DINO) entered into a Stock Purchase Agreement on May 18, 2026 to repurchase 1,455,180 shares of its common stock from REH Advisors Inc. at $68.72 per share for an aggregate purchase price of $100 million, funded with cash on hand. This is the twenty-first such privately negotiated transaction with REH and brings total repurchases under the company's $1 billion share repurchase program to $717 million. The transaction is expected to close on or around May 21, 2026, but the program may be discontinued at any time by the Board.

• · The repurchase price per share is $68.72, representing a premium/discount to market price (not specified).
• · The shares repurchased will be held as treasury stock.
• · The repurchase is the twenty-first privately negotiated transaction between the company and REH Advisors Inc.
• · The program may be discontinued at any time by the Board of Directors.
• · Future repurchases depend on market conditions, corporate, tax, regulatory and other considerations.

19-05-2026

Moving iMage Technologies (MITQ) reported Q3 FY2026 revenue of $3.39M, down 4.9% YoY from $3.57M, due to seasonally slow customer activity. However, gross margin improved to 34.8% from 29.8%, and net loss narrowed to ($122k) from ($240k). The company highlighted initial traction from its DCS loudspeaker line ($460k sales) and provided Q4 revenue guidance of ~$5.3M.

• · Nine-month FY2026 revenue was $12.77M vs $12.26M in prior year period.
• · Nine-month FY2026 net loss was ($1k) vs ($792k) in prior year period.
• · Cash used in operating activities for nine months FY2026 was ($3.30M) vs $91k provided in prior year period.
• · DCS sales in Q2 FY2026 were $22k, compared to $460k in Q3 FY2026.
• · Q4 FY2026 gross margin guidance is 25%-30%, up from 20%-25% in Q4 FY2025.
• · Company has zero debt.
• · Accounts receivable increased to $1.63M from $1.46M at June 30, 2025.
• · Inventories increased to $3.18M from $2.07M at June 30, 2025.
• · Customer deposits decreased to $270k from $1.10M at June 30, 2025.
• · Accumulated deficit remained nearly unchanged at ($7.205M) vs ($7.204M) at June 30, 2025.

19-05-2026

Envirotech Vehicles reported a net loss of $3.99M for Q1 2026 compared to a net loss of $14.04M in Q1 2025, primarily due to a $10.1M goodwill impairment charge in the prior year that did not recur. Revenue surged 281% YoY to $2.25M from $0.59M, but gross profit was negative $(0.19M) versus $0.12M in the prior year period. Operating expenses fell sharply, leading to a reduced operating loss of $(3.77M) from $(13.73M). However, cash used in operations remained high at $3.34M, and the company ended the quarter with a stockholders' deficit of $(8.18M) and total current liabilities far exceeding current assets.

• · Property and equipment, net increased dramatically from $0.48M to $2.25M quarter-over-quarter, driven by $1.84M in construction in progress.
• · Right-of-use asset increased from $0.49M to $1.95M quarter-over-quarter, and operating lease liabilities (short- and long-term) increased from $0.54M to $1.62M.
• · Cash used in operating activities improved to $(3.34M) from $(4.22M) in Q1 2025.
• · No goodwill impairment charge was recorded in Q1 2026 compared to a $10.1M charge in Q1 2025.
• · The company issued 4.57M shares of common stock for cash proceeds of $2.68M, and received $3.82M from debenture issuance during Q1 2026.
• · Total current liabilities of $18.31M exceed total current assets of $6.77M by a significant margin as of March 31, 2026.
• · The company had a stockholders' deficit of $(8.18M) as of March 31, 2026, though this improved slightly from $(8.93M) at year-end 2025.
• · Receivable from related party increased to $1.60M from $1.20M, and prepaid expenses rose to $0.35M from $0.24M.
• · G&A expenses remained virtually flat at $3.57M vs $3.60M year-over-year.
• · Basic and diluted net loss per share improved sharply to $(0.31) from $(6.44) due to the reduced loss and a much higher weighted average share count (12.89M vs 2.18M).

19-05-2026

Cellectar Biosciences, Inc. filed an S-1 registration statement with the SEC on May 19, 2026, for a proposed public offering of securities. The filing includes exhibits related to the company's capital stock, warrants, and material agreements, but does not disclose the number of shares or the proposed offering price. The registration statement is preliminary and subject to SEC review.

• · The filing includes exhibits for multiple series of preferred stock (Series D, Series E) and various warrants (Tranche A, Tranche B, Series I, Series II, Common Stock Purchase Warrants A/B/C).
• · The registration statement incorporates by reference the company's annual report on Form 10-K filed on March 13, 2025.
• · The filing includes a consent from Deloitte & Touche LLP, the independent registered public accounting firm.
• · The company has a history of multiple amendments to its certificate of incorporation and various equity financing transactions dating back to 2011.

19-05-2026

Energy Transition Special Opportunities (ticker ETSS U) priced its $150 million initial public offering of 15,000,000 units at $10.00 per unit on May 14, 2026, with the units expected to begin trading on the NYSE on May 15, 2026. The blank check company intends to target businesses in climate transition, specialty finance, renewable energy, and regenerative agriculture. The offering is expected to close on May 18, 2026, subject to customary conditions, and the underwriters have a 45-day option to purchase up to an additional 2,250,000 units to cover over-allotments.

• · The Company is a blank check company formed to effect a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination.
• · Target sectors include climate transition, specialty finance, renewable energy, and regenerative agriculture.
• · The registration statement was declared effective by the SEC on May 14, 2026.
• · The underwriters have a 45-day option to purchase up to an additional 2,250,000 units at the IPO price to cover over-allotments.
• · Once separate trading begins, Class A ordinary shares will trade under 'ETSS' and warrants under 'ETSS WS' on the NYSE.

19-05-2026

Monopar Therapeutics announced positive results from the Phase 2 ALXN1840-WD-204 study, showing that ALXN1840 (tiomolibdate choline) improves copper balance in patients with Wilson disease. The press release was issued on May 19, 2026, and furnished as Exhibit 99.1 to the 8-K filing. No financial figures or period-over-period comparisons were provided in this filing.

• · The study is a Phase 2 trial (ALXN1840-WD-204) evaluating ALXN1840 in Wilson disease.
• · ALXN1840 is a copper-binding agent (tiomolibdate choline) designed to improve copper balance.
• · The filing is a Regulation FD disclosure under Item 7.01, meaning the information is furnished, not filed, for SEC purposes.

19-05-2026

Paramount Skydance Corp (PSKY) disclosed plans to acquire Warner Bros. Discovery (WBD) and launched offers to purchase up to $2.4B in WBD notes and exchange up to $12.8B in WBD notes for new PSKY debt. The company also outlined a $51.9B acquisition financing plan ($39.5B first-lien and $12.4B second-lien secured debt) and committed to deleveraging targets of net debt/EBITDA below 3.75x by FY2028 and 3.0x by FY2029. However, the offers and financing are contingent on closing the acquisition, and the company cautioned that market conditions could alter the terms or feasibility of the financing.

• · The Offers are conditioned on receipt of requisite consents for Proposed Amendments to indentures and consummation of the Acquisition.
• · The Consent Solicitations seek to extend the deadline for the Required Exchange Transaction from December 30, 2026 to March 4, 2027 (or later if Merger Agreement terminated).
• · Paramount expects to achieve approximately 30% of over $6B synergies by first year post-closing, 70% by second year, and full run-rate by third year.
• · The New PSKY Notes are being offered only to qualified institutional buyers (Rule 144A) or non-U.S. persons (Regulation S).
• · The unaudited pro forma financial statements are attached as Exhibit 99.2 and incorporate historical financials from Paramount, WBD, and Skydance.

19-05-2026

DeFi Development Corp. reported Q1 2026 revenue of $2.7M, up 828% YoY from $0.3M, driven by digital asset revenue. However, the company posted a net loss of $83.4M compared to a $0.8M loss in the prior year, primarily due to a $51.0M net loss on digital assets and $22.8M loss from derivative instruments. Operating expenses surged to $57.9M from $1.2M, and cash used in operations increased to $9.8M from $0.8M.

• · Net loss per share (basic and diluted) was $(3.18) for Q1 2026 vs $(0.08) for Q1 2025.
• · Digital assets at fair value totaled $11.3M, with $10.4M pledged as collateral.
• · Non-cash digital asset financing arrangement borrowings were $91.1M, with repayments of $56.7M.
• · The company repurchased $10.5M of common stock during Q1 2026.
• · Cash paid for interest increased to $3.3M from $1,000 in the prior year period.
• · Accumulated deficit grew to $(175.3M) at March 31, 2026 from $(91.8M) at December 31, 2025.

19-05-2026

KraneShares Trust filed definitive additional proxy materials (DEFA14A) on May 19, 2026, amending its March 1, 2026 Proxy Statement regarding Proposal 2 for the KraneShares Bosera MSCI China A 50 Connect Index ETF (KBA). The amendment clarifies that all Krane-managed funds except KBA, BNDD, and IVOL have already received shareholder authorization to rely on the Manager of Managers (MoM) Exemptive Order, and that separate proxy materials will be filed for BNDD and IVOL. The filing does not contain any financial results or performance data.

• · The filing is a DEFA14A (Definitive Additional Materials) filed on May 19, 2026.
• · The original Proxy Statement was dated March 1, 2026.
• · The amendment specifically revises the section titled 'Proposal 2: To Authorize KBA to Rely on the Manager of Managers Exemptive Order'.
• · All Krane-managed funds except KBA, BNDD, and IVOL have already received shareholder authorization for the MoM Order.
• · A separate proxy statement will be furnished to shareholders of BNDD and IVOL for approval of a new investment sub-advisory agreement.

19-05-2026

Kimbell Royalty Partners, LP announced a $147 million acquisition of mineral and royalty interests from Mesa Royalties in the Permian Basin, expected to close in Q2 2026. The deal is funded with 70% newly issued OpCo units and 30% cash, and is expected to be immediately accretive to distributable cash flow per unit. The acquired assets include over 2,300 gross producing wells and over 600 undeveloped locations, with estimated NTM cash flow of $23.3 million.

• · The acquisition is expected to close in Q2 2026 with an effective date of June 1, 2026.
• · Kimbell's oil weighting is expected to increase from 32% to 33% of daily production mix.
• · Over 98% of all rigs in the continental US are located in counties where Kimbell will hold mineral interests post-acquisition.
• · The purchase price per total proved Boe is approximately $19.17.
• · The acquired assets are located across 15 Permian counties, with 70% in Delaware Basin and 30% in Midland Basin.

19-05-2026

York Space Systems Inc. announced on May 15, 2026 its plan to acquire all equity interests of Solestial, Inc. The consideration consists of up to ~2.35 million shares of York common stock plus cash, with the transaction expected to close in Q2 2026. The shares will be issued in reliance on an exemption from registration under the Securities Act.

• · The filing relates to Item 3.02 (Unregistered Sales of Equity Securities) — the shares will be issued under Section 4(a)(2) or Regulation D, not registered under the Securities Act.
• · The shares issued are subject to transfer restrictions under the Merger Agreement.
• · The filing notes forward-looking risk factors including uncertainties as to timing, regulatory approvals, and potential disruption to current business plans.

19-05-2026

Relay Therapeutics announced initial clinical data from the Phase 2 ReInspire trial of zovegalisib in vascular anomalies. Among 20 response-evaluable patients, 60% had a volumetric response, with all responses at first MRI, and 95% experienced lesion reduction. However, the 400mg BID dose was deprioritized due to suboptimal safety, and safety, and 23% of patients at lower doses required dose reductions, though no discontinuations occurred.

• · All 32 patients remained on treatment as of the data cut-off date (April 15, 2026).
• · Responses were observed across a spectrum of PIK3CA mutations, including both kinase and non-kinase mutations.
• · No rash or stomatitis of any grade was observed, and no grade 3 hyperglycemia or diarrhea was observed at 100mg/300mg BID.
• · No prophylactic treatment was administered for management of any adverse event.
• · The 400mg BID dose was deprioritized for further development due to suboptimal safety profile.
• · The company is developing a fit-for-purpose patient-reported outcome tool for the trial population.

19-05-2026

Lifeloc Technologies reported Q1 2026 net revenue of $2.294M, up 1% YoY from $2.277M, and a net loss of $(153)K (or $(0.06) per share), improving from a $(293)K loss in Q1 2025. Gross margin improved to 43% from 40% due to pricing and product mix, while R&D spending declined but remained above 18% of revenue. The company achieved a key milestone in SpinDetect™ development with completion of the production mold for its centrifugal drug analyzer, but cash and cash equivalents fell to $569K from $746K at year-end 2025, and the company secured a $500K loan from its Chairman and CFO in May 2026.

• · R&D spending declined to $414,445 in Q1 2026 from $469,680 in Q1 2025, an 11.8% decrease.
• · Accounts payable surged to $615,378 from $301,627 at year-end 2025, a 104% increase.
• · Inventories increased to $2,794,329 from $2,633,614 at December 31, 2025.
• · The company's accumulated deficit grew to $(1,983,249) from $(1,830,536) at year-end 2025.
• · Net cash used in operating activities was $(129,365) in Q1 2026 vs $(100,357) in Q1 2025.
• · The May 2026 loan of $500,000 carries a 10.5% interest rate, adjustable upward based on prime rate, with interest-only payments in 2026 and full repayment in 5 years.
• · SpinDetect™ has demonstrated detection of delta-9-THC, cocaine, fentanyl, amphetamine/methamphetamine, morphine, MDMA, and benzodiazepines from oral fluid, with a limit of detection of approximately 10 ng/ml.
• · First article moldings from the production mold were completed and delivered in April 2026 and are currently being evaluated.

19-05-2026

Under Armour reports a net loss of $495.6M for fiscal year 2026, significantly widening from a $201.3M loss in the prior year, driven by a 3.8% decline in net revenues to $5.0B and a $297.6M income tax expense versus a $2.9M tax benefit last year. While gross margin contracted 240 bps to 45.5%, the company reduced SG&A expenses by 11.8% and incurred $127.7M in restructuring charges as part of a transformation plan. Geographically, the business is mixed: North America declined 7.9% and Asia-Pacific fell 4.8%, but EMEA grew 8.6% and Latin America increased 8.7%.

• · Footwear net revenues declined 10.8% to $1.08B, the worst-performing product category.
• · Income tax expense swung from a $2.9M benefit to a $294.8M charge, contributing heavily to the wider net loss.
• · Wholesale channel revenues fell 4.9% to $2.83B, while DTC declined 1.7% to $2.05B.
• · Restructuring charges more than doubled to $127.7M, with remaining costs of $44.3M to be incurred (total program $305M).

19-05-2026

Aeluma, Inc. filed an 8-K on May 19, 2026, furnishing an updated investor presentation. The company highlights its breakthrough in large-diameter InGaAs-on-silicon manufacturing for SWIR sensors and photonics, targeting mobile, AI infrastructure, defense, and quantum markets. It reports $4.7M in recurring R&D revenue for FY25, $37.8M cash as of March 31, 2026, and no debt, but notes that outcomes cannot be guaranteed and forward-looking statements involve risks.

• · Aeluma is ISO 9001:2015 certified.
• · The company has no debt or overhang.
• · Aeluma's manufacturing platform claims 5-10X lower manufacturing cost versus incumbent technologies.
• · The presentation notes a major InP substrate supply shortage and limited InP fab capacity in the industry.
• · Aeluma's 300 mm substrate has 16X wafer area compared to a 3-inch substrate.

19-05-2026

Mascagni Wealth Management, Inc. filed its quarterly 13F-HR for the period ending March 31, 2026, reporting a total portfolio value of approximately $140.4 million across 127 equity holdings. The portfolio is heavily weighted toward ETFs, with top positions in iShares Convertible Bond ETF ($8.3M), NVIDIA Corp ($6.0M), Capital Group Dividend Value ETF ($5.7M), and Invesco S&P Midcap Quality ETF ($5.7M). While the filing shows significant exposure to technology and growth-oriented funds, it also includes substantial allocations to income and bond ETFs, indicating a balanced approach.

• · All 127 holdings are reported with sole voting and dispositive power; no shared or non-voting positions.
• · The portfolio includes 0 put/call options; all positions are common stock or ETFs.
• · Top 10 holdings by value: iShares Convertible Bond ETF ($8.3M), NVIDIA ($6.0M), Capital Group Dividend Value ETF ($5.7M), Invesco S&P Midcap Quality ETF ($5.7M), iShares High Yield Bond ETF ($4.9M), Apple ($5.1M), Invesco S&P 500 Momentum ETF ($3.9M), Schwab International Equity ETF ($3.8M), Microsoft ($3.5M), and Capital Group Core Balanced ETF ($2.7M).
• · Significant sector exposure includes technology (NVIDIA, Apple, Microsoft, Broadcom, Meta, Alphabet), fixed income (convertible bonds, high yield, corporate bonds, treasuries), and international equities (Schwab International Equity ETF, Vanguard FTSE Europe, Capital Group Global Growth).
• · The portfolio holds a mix of growth (Invesco S&P 500 Momentum, iShares Russell 1000 Growth) and value (SPDR S&P 500 Value, Vanguard Value Index) ETFs, suggesting a balanced style approach.
• · No prior period comparison data is available in this filing to assess changes in holdings or performance.

19-05-2026

Federal Home Loan Bank of Chicago filed an 8-K disclosing the issuance of consolidated obligation bonds and discount notes on trade dates May 13 and May 15, 2026. The total par value of the reported issuances is $245 million, with maturities ranging from 2027 to 2046 and fixed coupon rates between 4.050% and 5.750%. These obligations are joint and several liabilities of the eleven Federal Home Loan Banks, are not guaranteed by the U.S. government, and are issued under FHFA regulation.

• · All reported bonds are callable (Optional Principal Redemption) with either American or Bermudan call styles.
• · The longest maturity is 20 years (2046) with the highest coupon of 5.750%.
• · The largest single issuance is $100 million (8/19/2027 maturity, 4.050% coupon).
• · The filing excludes discount notes with maturity ≤1 year issued in ordinary course.
• · Consolidated obligations are joint and several obligations of all eleven Federal Home Loan Banks, not guaranteed by the U.S. government.

19-05-2026

Kinder Morgan, Inc. held its 2026 Annual Meeting on May 13, 2026, where shareholders elected all 11 director nominees, ratified PricewaterhouseCoopers LLP as auditor for 2026, and approved executive compensation on an advisory basis. All proposals passed with strong support, though director Ted A. Gardner received the lowest 'for' votes (1,481,686,656) and highest 'against' votes (206,267,328) among nominees.

• · A quorum of 1,974,609,446 shares was present at the meeting.
• · Proposal Two (ratification of auditor) received 1,884,515,068 votes for, 87,297,841 against, and 2,796,421 abstentions, with no broker non-votes.
• · Proposal Three (advisory vote on executive compensation) received 1,605,994,160 votes for, 77,788,484 against, and 6,461,209 abstentions, with 284,365,592 broker non-votes.
• · Director Ted A. Gardner had the lowest support with 1,481,686,656 for votes and 206,267,328 against.

19-05-2026

Mobix Labs, Inc. amended its senior secured convertible note with Leviston Resources, increasing the principal from $3M to $4M and receiving an additional $833,333 cash advance. The entire $4M principal plus accrued interest was subsequently converted into 2,500,000 shares of Class A Common Stock between May 12-18, 2026, fully satisfying the note. The company also entered an Investor Rights Agreement granting Leviston the option to acquire up to $4.0M in additional secured convertible notes over seven months on similar terms.

• · The Original Note was originally issued on March 31, 2026.
• · Leviston at no time beneficially owned in excess of 4.99% of outstanding Class A Common Stock.
• · The conversion was exempt from registration under Section 3(a)(9) of the Securities Act.
• · The Original Note, Securities Purchase Agreement, and Registration Rights Agreement terminated upon full satisfaction.
• · The Investor Rights Agreement grants Leviston the right to acquire up to $4.0M in additional secured convertible notes on a pari passu basis over seven months.

19-05-2026

Federal Home Loan Bank of Des Moines issued a schedule of consolidated obligations (callable and non-callable bonds) totaling approximately $551 million across 10 tranches, with settlement dates in May 2026 and maturities ranging from 2027 to 2056. The offerings include fixed-rate, variable-rate (single index floater), and non-callable notes, with coupon rates from 4.00% to 6.00% and call features (American, Bermudan, European).

• · The largest tranche is a $300M variable single index floater (callable, European style, matures 2028).
• · The longest maturity is a $25M fixed 6.00% callable bond maturing in 2056 (Bermudan call style).
• · Two non-callable fixed-rate tranches (4.01%) total $21M, maturing in 2031.
• · All callable bonds have first call dates in 2026 or 2027.
• · The filing is a direct financial obligation under Item 2.03 of Form 8-K.